LCGC EUROPE is a prominent journal dedicated to the field of analytical chemistry, specifically highlighting the latest trends and innovations in chromatographic techniques. Published by MJH Life Sciences, this journal has served as a valuable resource for researchers, professionals, and students interested in the nuances of laboratory practices and the advancement of instrumentation. Although LCGC EUROPE ceased its coverage in Scopus from 2018, it has maintained a significant influence within the community, evidenced by its Scopus rank of 90/114 in Analytical Chemistry, placing it in the 21st percentile. With its inception dating back to 1996, the journal provided essential insights and peer-reviewed articles, fostering a rich understanding of chromatographic science. While the journal is not currently open access, it remains an integral part of the literature for anyone engaged in the analytical chemistry landscape, especially as it pertains to laboratory methodologies and innovations.

The Journal of Mass Spectrometry, published by Wiley, is a vital resource for researchers and professionals in the fields of chemistry and medicine. With an ISSN of 1076-5174 and an E-ISSN of 1096-9888, this journal specializes in the latest advancements in mass spectrometry, an essential analytical tool used in various applications including drug development, environmental monitoring, and biological research. Positioned in the Q3 quartile for both Medicine (miscellaneous) and Spectroscopy categories in 2023, the journal stands out for its commitment to disseminating high-quality research findings. Its Scopus ranking places it at 36th in the field of Chemistry _ Spectroscopy, within the 53rd percentile, reflecting its growing impact and relevance. Researchers are encouraged to submit their work and explore cutting-edge articles published between 1995 and 2024. Despite its non-open access model, the journal remains accessible through various academic platforms, fostering a rich exchange of knowledge among scientists worldwide.

Analytical & Bioanalytical Electrochemistry is a pivotal journal dedicated to the advancement of research and innovation in the fields of analytical chemistry and electrochemistry. Published by the University of Tehran, Faculty of Chemistry, Center of Excellence in Electrochemistry, this journal has been contributing to the scientific community since its inception in 2009 and continues to be a critical platform through 2024. With an ISSN of 2008-4226, it focuses on a variety of topics including electrochemical sensors, bioanalytical techniques, and innovative methodologies in electrochemical analysis. Although it currently holds a Q4 quartile ranking in both analytical chemistry and electrochemistry categories, its unique insights and research findings are essential for advancing knowledge and fostering interdisciplinary collaboration within the scientific community. Researchers, professionals, and students engaged in these dynamic fields will find valuable resources and contribute to the ongoing discourse by publishing their work in this journal. We invite you to explore and engage with the diverse content that Analytical & Bioanalytical Electrochemistry offers to enhance your research and professional development.

Biomedical Chromatography is a prestigious journal published by Wiley, focusing on the vital intersections of analytical chemistry, biochemistry, and clinical studies. With an ISSN of 0269-3879 and E-ISSN of 1099-0801, it has served the research community since its inception in 1986. The journal provides a platform for innovative research in areas such as drug discovery and pharmacology, achieving a commendable placement in Q3 across multiple categories in the 2023 metrics, including Analytical Chemistry and Biochemistry. Although it currently does not offer open access, it plays a crucial role in disseminating scientific developments and methodologies that contribute to advancements in health, safety, and pharmaceuticals. Researchers, professionals, and students can anticipate high-quality, peer-reviewed articles that drive forward the collective knowledge in biomedical applications. Located in the United Kingdom at 111 River St, Hoboken, NJ, the journal continues to attract contributions from global thought leaders in the field.

Biochemia Medica is a premier open-access journal that has been at the forefront of advancing knowledge in the fields of medical biochemistry and laboratory medicine since its inception in 2006. Published by the Croatian Society of Medical Biochemistry & Laboratory Medicine, this journal serves a vital role in disseminating high-quality research findings and reviews that contribute to the understanding of biochemical processes in health and disease. With an impressive performance in the Scopus ranking, it holds a Q2 quartile category in both medical biochemistry and clinical biochemistry for 2023, reflecting its commitment to scholarly excellence and relevance in the field. As an open-access journal, Biochemia Medica ensures that research is freely accessible, fostering collaboration and innovation among researchers, healthcare professionals, and students globally. Positioned within a rapidly evolving scientific landscape, this journal is dedicated to bridging the gap between laboratory research and clinical application, making it an indispensable resource for anyone interested in the intersections of biochemistry and medicine.

DRUGS is a prestigious, peer-reviewed journal published by ADIS INT LTD, specializing in the field of pharmacology across diverse medical applications. With an impressive impact factor and ranking as Q1 in the Pharmacology (Medical) category as per the 2023 metrics, this journal consistently exhibits a strong influence in the medical research community, holding a notable rank of #3 out of 272 in its domain on Scopus, placing it within the 99th percentile. Established in 1971 and converging its insightful contributions until 2024, DRUGS encompasses a broad scope, focusing on the latest advancements in drug research, development, and clinical applications, aiming to bridge the gap between laboratory discoveries and therapeutic practices. Though not an Open Access journal, it remains a key resource for researchers, professionals, and students keen on exploring cutting-edge findings and developments in pharmacology. Its location in the United Kingdom further emphasizes its role as a global leader in pharmaceutical sciences.

Separation Science Plus is an emerging academic journal dedicated to advancing the field of analytical chemistry and separation science. Published by WILEY-VCH Verlag GmbH, this journal provides a platform for researchers to disseminate high-quality studies and reviews that address innovative techniques and breakthroughs in separation methodologies. With its ISSN 2573-1815, the journal has made significant inroads since its inception in 2018, encompassing a convergence period until 2024. Despite currently holding a Q3 ranking in Analytical Chemistry and a Q4 ranking in Filtration and Separation, its dedication to publishing impactful research makes it a vital resource for professionals and students alike. The journal operates under the robust scholarly reputation of WILEY, which is known for its commitment to excellence in scientific communication. Researchers interested in the latest advancements in separation techniques will find Separation Science Plus an essential read, fostering the exchange of knowledge and facilitating greater understanding within this specialized field.

CHEMICAL RESEARCH IN CHINESE UNIVERSITIES is a prominent academic journal dedicated to the dissemination of high-quality research in the field of chemistry and related educational methodologies. Published by HIGHER EDUCATION PRESS, this journal has established itself as a vital resource for researchers and professionals looking to stay at the forefront of chemical sciences. With an impressive impact factor and ranked in the Q2 quartile for both Chemistry and Education categories, it highlights significant advancements while maintaining rigorous peer-review standards. The journal's ISSN is 1005-9040 and its E-ISSN is 2210-3171, ensuring broad accessibility to its global readership. Although it does not offer open access, its contributions are vital to understanding the dynamics of chemistry research and education within and beyond China. With converged publication years from 1999 through to 2024, CHEMICAL RESEARCH IN CHINESE UNIVERSITIES continues to be an essential platform for innovative studies and critical discussions in the expanding realm of chemistry.

Translational Research, published by Elsevier Science Inc, stands at the forefront of the rapidly evolving fields of biochemistry, medicine, physiology, and public health. With an impressive 2023 Q1 ranking in these categories, this journal has established itself as a critical platform for disseminating innovative research that bridges the gap between laboratory findings and clinical application. The journal, which has been converging knowledge since 2006, is committed to advancing scientific understanding and improving health outcomes by publishing high-quality articles that reflect rigorous peer review and impactful findings. With its impressive Scopus rankings, including a rank of #5 in Biochemistry and #7 in Physiology, it is an essential resource for researchers, practitioners, and students dedicated to the translation of scientific breakthroughs into real-world health solutions. Transitioning to an open-access model, the journal enhances accessibility and engagement, inviting a global audience to participate in the discourse shaping the future of healthcare and disease management.

The Journal of Pharmaceutical and Biomedical Analysis, published by ELSEVIER and available in print and online formats, stands as a pivotal source of knowledge in the realms of Analytical Chemistry, Clinical Biochemistry, Drug Discovery, and Pharmaceutical Science. With an ISSN of 0731-7085 and an e-ISSN of 1873-264X, this journal is dedicated to publishing high-quality research that advances the understanding and development of analytical techniques in pharmaceuticals and biomedicine. The journal has earned a solid reputation, reflected in its Q2 category rankings across five distinct fields for 2023, and boasts impressive Scopus rankings, signaling its robust impact within the academic community. The Journal of Pharmaceutical and Biomedical Analysis serves as an essential resource for researchers, professionals, and students alike, providing actionable insights and fostering innovation that can directly influence future advancements in drug development and biomedical applications.